146 related articles for article (PubMed ID: 31306217)
21. Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]).
Hänggi D; Etminan N; Aldrich F; Steiger HJ; Mayer SA; Diringer MN; Hoh BL; Mocco J; Faleck HJ; Macdonald RL;
Stroke; 2017 Jan; 48(1):145-151. PubMed ID: 27932607
[TBL] [Abstract][Full Text] [Related]
22. Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.
Sandow N; Diesing D; Sarrafzadeh A; Vajkoczy P; Wolf S
Neurocrit Care; 2016 Aug; 25(1):29-39. PubMed ID: 26690937
[TBL] [Abstract][Full Text] [Related]
23. Simple and validated UHPLC-MS/MS analysis of nimodipine in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage.
Mohamed S; Riva R; Contin M
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():94-99. PubMed ID: 27327399
[TBL] [Abstract][Full Text] [Related]
24. Absorption, elimination and cerebrospinal fluid concentrations of nimodipine in healthy beagle dogs receiving human intravenous and oral formulation.
Koskimäki J; Tarkia M; Ahtola-Sätilä T; Saloranta L; Laakso A; Frantzén J
Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):295-300. PubMed ID: 25652785
[TBL] [Abstract][Full Text] [Related]
25. Higher Cerebrospinal Fluid pH may Contribute to the Development of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage.
Suzuki H; Shiba M; Nakatsuka Y; Nakano F; Nishikawa H
Transl Stroke Res; 2017 Apr; 8(2):165-173. PubMed ID: 27623837
[TBL] [Abstract][Full Text] [Related]
26. A randomized outcome study of enteral versus intravenous nimodipine in 171 patients after acute aneurysmal subarachnoid hemorrhage.
Soppi V; Karamanakos PN; Koivisto T; Kurki MI; Vanninen R; Jaaskelainen JE; Rinne J
World Neurosurg; 2012 Jul; 78(1-2):101-9. PubMed ID: 22120252
[TBL] [Abstract][Full Text] [Related]
27. Cerebral vasospasm and calcium channel blockade. Nimodipine treatment in patients with aneurysmal subarachnoid hemorrhage.
Brandt L; Ljunggren B; Säveland H; Andersson KE; Vinge E
Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():151-5. PubMed ID: 3521193
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic Modeling of Intra-arterial Nimodipine Therapy for Subarachnoid Hemorrhage-Related Cerebral Vasospasm.
Seker F; Hesser J; Brockmann MA; Neumaier-Probst E; Groden C; Schubert R; Brockmann C
Clin Neuroradiol; 2017 Jun; 27(2):199-203. PubMed ID: 26350588
[TBL] [Abstract][Full Text] [Related]
29. Nimodipine systemic exposure and outcomes following aneurysmal subarachnoid hemorrhage: a pilot prospective observational study (ASH-1 study).
Mahmoud SH; Hefny F; Isse FA; Farooq S; Ling S; O'Kelly C; Kutsogiannis DJ
Front Neurol; 2023; 14():1233267. PubMed ID: 38249736
[TBL] [Abstract][Full Text] [Related]
30. Impact of Early Versus Late Intravenous Followed by Oral Nimodipine Treatment on the Occurrence of Delayed Cerebral Ischemia Among Patients With Aneurysm Subarachnoid Hemorrhage.
Samseethong T; Suansanae T; Veerasarn K; Liengudom A; Suthisisang C
Ann Pharmacother; 2018 Nov; 52(11):1061-1069. PubMed ID: 29783859
[TBL] [Abstract][Full Text] [Related]
31. Does Nimodipine Interruption due to High Catecholamine Doses Lead to a Greater Incidence of Delayed Cerebral Ischemia in the Setting of Aneurysmal Subarachnoid Hemorrhage?
Hernández-Durán S; Mielke D; Rohde V; Malinova V
World Neurosurg; 2019 Dec; 132():e834-e840. PubMed ID: 31404696
[TBL] [Abstract][Full Text] [Related]
32. Excessive release of endogenous neuropeptide Y into cerebrospinal fluid after treatment of spontaneous subarachnoid haemorrhage and its possible impact on self-reported neuropsychological performance - results of a prospective clinical pilot study on good-grade patients.
Bründl E; Proescholdt M; Schödel P; Bele S; Höhne J; Zeman F; Stoerr EM; Brawanski A; Schebesch KM
Neurol Res; 2018 Dec; 40(12):1001-1013. PubMed ID: 30213237
[TBL] [Abstract][Full Text] [Related]
33. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
[TBL] [Abstract][Full Text] [Related]
34. Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid haemorrhage?
Goel R; Aggarwal A; Salunke P; Kumar A; Chhabra R
Br J Neurosurg; 2016 Aug; 30(4):407-10. PubMed ID: 26999260
[TBL] [Abstract][Full Text] [Related]
35. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration.
Kronvall E; Undrén P; Romner B; Säveland H; Cronqvist M; Nilsson OG
J Neurosurg; 2009 Jan; 110(1):58-63. PubMed ID: 18847340
[TBL] [Abstract][Full Text] [Related]
36. EARLYDRAIN- outcome after early lumbar CSF-drainage in aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.
Bardutzky J; Witsch J; Jüttler E; Schwab S; Vajkoczy P; Wolf S
Trials; 2011 Sep; 12():203. PubMed ID: 21917146
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage.
Liu GJ; Luo J; Zhang LP; Wang ZJ; Xu LL; He GH; Zeng YJ; Wang YF
CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):834-44. PubMed ID: 21999736
[TBL] [Abstract][Full Text] [Related]
38. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage.
Musahl C; Henkes H; Vajda Z; Coburger J; Hopf N
Neurosurgery; 2011 Jun; 68(6):1541-7; discussion 1547. PubMed ID: 21311378
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of an abbreviated course of nimodipine in patients with good-grade aneurysmal subarachnoid hemorrhage.
Toyota BD
J Neurosurg; 1999 Feb; 90(2):203-6. PubMed ID: 9950489
[TBL] [Abstract][Full Text] [Related]
40. Nimodipine after aneurysmal subarachnoid hemorrhage: Fourteen-day course for patients that meet criteria for early hospital discharge.
Sokolowski JD; Chen CJ; Soldozy S; Mastorakos P; Burke RM; Nguyen JM; Myers KM; Kalani MYS; Park MS
Clin Neurol Neurosurg; 2021 Jan; 200():106299. PubMed ID: 33092929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
